232 related articles for article (PubMed ID: 24386459)
1. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
[TBL] [Abstract][Full Text] [Related]
2. Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin.
Barthel SR; Gavino JD; Wiese GK; Jaynes JM; Siddiqui J; Dimitroff CJ
Glycobiology; 2008 Oct; 18(10):806-17. PubMed ID: 18647941
[TBL] [Abstract][Full Text] [Related]
3. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).
Myung JH; Launiere CA; Eddington DT; Hong S
Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985
[TBL] [Abstract][Full Text] [Related]
5. In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cells.
Gakhar G; Bander NH; Nanus DM
J Vis Exp; 2014 May; (87):. PubMed ID: 24894373
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
Barthel SR; Wiese GK; Cho J; Opperman MJ; Hays DL; Siddiqui J; Pienta KJ; Furie B; Dimitroff CJ
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19491-6. PubMed ID: 19889975
[TBL] [Abstract][Full Text] [Related]
7. E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis.
Yasmin-Karim S; King MR; Messing EM; Lee YF
Oncotarget; 2014 Dec; 5(23):12097-110. PubMed ID: 25301730
[TBL] [Abstract][Full Text] [Related]
8. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
[TBL] [Abstract][Full Text] [Related]
9. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.
Hsu JW; Yasmin-Karim S; King MR; Wojciechowski JC; Mickelsen D; Blair ML; Ting HJ; Ma WL; Lee YF
Am J Pathol; 2011 Feb; 178(2):872-80. PubMed ID: 21281819
[TBL] [Abstract][Full Text] [Related]
10. HECA-452 is a non-function blocking antibody for isolated sialyl Lewis x adhesion to endothelial expressed E-selectin under flow conditions.
Kummitha CM; Shirure VS; Delgadillo LF; Deosarkar SP; Tees DF; Burdick MM; Goetz DJ
J Immunol Methods; 2012 Oct; 384(1-2):43-50. PubMed ID: 22820001
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion.
Geng Y; Chandrasekaran S; Hsu JW; Gidwani M; Hughes AD; King MR
PLoS One; 2013; 8(1):e54959. PubMed ID: 23372803
[TBL] [Abstract][Full Text] [Related]
13. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
[TBL] [Abstract][Full Text] [Related]
14. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides expressed on breast cancer cells are E-selectin ligands.
Shirure VS; Henson KA; Schnaar RL; Nimrichter L; Burdick MM
Biochem Biophys Res Commun; 2011 Mar; 406(3):423-9. PubMed ID: 21329670
[TBL] [Abstract][Full Text] [Related]
16. PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow.
Zou X; Shinde Patil VR; Dagia NM; Smith LA; Wargo MJ; Interliggi KA; Lloyd CM; Tees DF; Walcheck B; Lawrence MB; Goetz DJ
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C415-24. PubMed ID: 15814589
[TBL] [Abstract][Full Text] [Related]
17. Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells.
Dimitroff CJ; Descheny L; Trujillo N; Kim R; Nguyen V; Huang W; Pienta KJ; Kutok JL; Rubin MA
Cancer Res; 2005 Jul; 65(13):5750-60. PubMed ID: 15994950
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenic potential of circulating prostate tumor cells.
Carvalho FL; Simons BW; Antonarakis ES; Rasheed Z; Douglas N; Villegas D; Matsui W; Berman DM
Oncotarget; 2013 Mar; 4(3):413-21. PubMed ID: 23530114
[TBL] [Abstract][Full Text] [Related]
19. Analysis of physiologic E-selectin-mediated leukocyte rolling on microvascular endothelium.
Wiese G; Barthel SR; Dimitroff CJ
J Vis Exp; 2009 Feb; (24):. PubMed ID: 19229187
[TBL] [Abstract][Full Text] [Related]
20. Ezrin expression in circulating tumor cells is a predictor of prostate cancer metastasis.
Chen Z; Wang J; Lu Y; Lai C; Qu L; Zhuo Y
Bioengineered; 2022 Feb; 13(2):4076-4084. PubMed ID: 35156523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
